GENOMIC HEALTH INC
DelistedCIK 1131324fmd_03MEH7SRNDCQXEK65WDCQHBZW8Services · Services-Medical LaboratoriesTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2019, 39 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 150 | 178 | 206 | 235 | 262 | 276 | 287 | 328 | 341 | 394 |
| Cost of revenue | 33 | 35 | 34 | 37 | 42 | 49 | 55 | 59 | 55 | – |
| Gross profit | 117 | 143 | 172 | 198 | 219 | 227 | 232 | 269 | 286 | – |
| Research and development | 36 | 33 | 40 | 49 | 64 | 53 | 58 | 60 | 63 | 64 |
| Selling, general and administrative | 91 | 106 | 124 | 141 | 167 | 198 | 208 | 224 | 230 | 242 |
| Operating income | (9) | 4 | 8 | 8 | (12) | (24) | (34) | (15) | (6) | 24 |
| Interest and investment income | – | – | – | – | – | – | 0 | 0 | 1 | 2 |
| Other non-operating income (expense) | (0) | (0) | (0) | (0) | (0) | (1) | (0) | (1) | 0 | (0) |
| Income before taxes | (9) | 4 | 8 | 9 | (12) | (24) | (34) | (13) | (2) | 27 |
| Income tax expense | 1 | (0) | 0 | 0 | 0 | 0 | (1) | 1 | 2 | 1 |
| Net income from continuing operations | (9) | 4 | 8 | 8 | (13) | (25) | (33) | (14) | (4) | 26 |
| Net income | – | – | – | – | – | – | (33) | (14) | (4) | 26 |
| Net income to common shareholders | (9) | 4 | 8 | 8 | (13) | (25) | (33) | (14) | (4) | 26 |